Amidst uncertainty, risk-bearing providers and ACOs must be nimble and adaptable to mitigate losses. What strategies can be deployed to support value-based financial and clinical goals?
In the fall, plans will be challenged by the double whammy of a presidential election and a predicted second outbreak of COVID-19. This AIS Health article in Health Plan Weekly shares some insights from a recent GHG/Deft Research webinar and the product strategy implications of a changed selling environment.
On March 30, 2020, CMS released the interim final rule with comment period (IFC) to address a variety of payment and provider practice needs in response to the COVID-19 pandemic. Read the key takeaways for Star Ratings, Provider Flexibilities, and Telehealth.
The 2021 Medicare Advantage and Part D Rate Announcement finalizes the payment methodology and policies previously proposed by the Advance Notice. What’s been confirmed? Read this article for details.
CMS recently broadened access and greatly relaxed regulations around telehealth services for Medicare beneficiaries. What does this mean for Medicare Advantage plans and providers?
The reality of social distancing and “shelter in place” orders has forced many to find a new way of working outside of a physical office. Since GHG’s team is fully remote, we wanted to share some advice for those new to working from home.
GHG’s Senior Vice President of Stars & Strategy, Melissa Smith, talks crucial Star Ratings implications from the CMS 2021 and 2022 MA and Part D Proposed Rule in a recent AIS Health article in RADAR on Medicare Advantage.
With bid submissions on the horizon, CMS’ recently announced Advance Notice and Proposed Rule should be top of mind for product strategy leaders. Read our key takeaways.
The countdown for network development, expansion, and Health Service Delivery (HSD) submission for 2020 is upon us. It is imperative that network strategy planning starts now in order to avoid the pitfalls plans have faced in the past.